Eupraxia Pharmaceuticals hosts analyst day on EP-104GI for eosinophilic esophagitis

EPRX•2026-10-22

Eupraxia Pharmaceuticals will host a virtual analyst day on EP-104GI for eosinophilic esophagitis on November 13, 2026, and participate in four other healthcare events in October and November.

1. Upcoming events

Eupraxia Pharmaceuticals will host a virtual analyst day on EP-104GI for eosinophilic esophagitis on November 13, 2026, at 8:30 a.m. ET. Management will join the Craig Hallum Biotech Catalyst Virtual Conference on October 22, with a fireside chat at 10:30 a.m. ET, and participate in BIO-Europe in Cologne from November 9-11 with one-on-one meetings. The company is also scheduled for the Stifel 2026 Healthcare Conference in New York, including a fireside chat on November 10 at 4:40 p.m. ET, and the Jefferies Global Healthcare Conference in London, with a presentation on November 16 at 1:30 p.m. GMT.

Eupraxia Pharmaceuticals hosts analyst day on EP-104GI for eosinophilic esophagitis

1. Upcoming events

Related News

Riot Platforms: ATB Cormark cuts target price to $30 from $36

B. Riley raises Veradermics target price to $204 from $170

Greene County Bancorp's Q1 net income rises 41%

Microchip Technology target price cut to $98 from $108

SUI Group schedules third-quarter earnings conference call